The benefit of induction chemotherapy in patients age ? 75 years-Reference-Cited by-同舟云学术

The benefit of induction chemotherapy in patients age ? 75 years

Published:2004 Issue:2 Volume:101 Page:325-331
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Vey Norbert,Coso Diane,Bardou Valerie-Jeanne,Stoppa Anne-Marie,Braud Anne-Chantal,Bouabdallah Reda,Sainty Daniele,Mozziconacci Marie-Joelle,Lafage Marina,Damaj Gandhi,Blaise Didier,Gastaut Jean-Albert,Maraninchi Dominique

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. INTENSIVE INDUCTION CHEMOTHERAPY IN ELDERLY PATIENTS

2. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

3. A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)

4. A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study;Annals of Hematology;2024-01-26

2. Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review;PLOS ONE;2022-12-05

3. Determination of fitness and therapeutic options in older patients with acute myeloid leukemia;American Journal of Hematology;2021-01-12

4. Treatment of Newly Diagnosed AML in Unfit Patients;Acute Myeloid Leukemia;2021

5. Benchmarking treatment effects for patients over 70 with acute myeloid leukemia: A systematic review and meta-analysis;Journal of Geriatric Oncology;2020-11